Kairos Pharma, LTD.

Ownership Transactions Reported by 7 Insiders

Symbol
KAPA on NYSE
Location
2355 Westwood Blvd. #139, Los Angeles, CA

Insiders trading volume in the past year

Kairos Pharma, LTD. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John S. Yu CEO and Chairman, Director, 10%+ Owner $8.52M +$5.76K +0.07% Jan 1, 2025
Neil Bhowmick Chief Scientific Officer $1.81M Jan 1, 2025
Ramachandran Murali VP of Research and Development $234K +$318 +0.14% Jan 1, 2025
Doug Samuelson Chief Financial Officer $91.2K +$3.75K +4.29% Nov 22, 2024
Hyun W. Bae Director $63.8K Sep 16, 2024
Hansoo Michael Keyoung Director Sep 16, 2024
Rosemary Mazanet Director Sep 16, 2024

Recent Insider Transactions by Companies or Individuals for Kairos Pharma, LTD.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.